Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Spatial-spectral characterization and mapping of labeled drusenoid deposits in non-neovascular age-related macular degeneration
Author Affiliations & Notes
  • Khaled Nassar
    Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Rhineland-Palatinate, Germany
  • Heiko Niessen
    Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Rhineland-Palatinate, Germany
  • Jean Daniel Arbour
    Clinique Ophtalmologique 2121, Montréal, Quebec, Canada
  • Marc-André Rhéaume
    Clinique Ophtalmologique 2121, Montréal, Quebec, Canada
  • Ramina Nissan
    Optina Diagnostics, Montréal, Quebec, Canada
  • Anthéa Rojewski
    Optina Diagnostics, Montréal, Quebec, Canada
  • Patricia Sorya
    Optina Diagnostics, Montréal, Quebec, Canada
  • Lara Santucci
    Optina Diagnostics, Montréal, Quebec, Canada
  • Shannon Campbell
    Optina Diagnostics, Montréal, Quebec, Canada
  • Samin Sabokrohiyeh
    Optina Diagnostics, Montréal, Quebec, Canada
  • Anudeep Konda
    Optina Diagnostics, Montréal, Quebec, Canada
  • Claudia Chevrefils
    Optina Diagnostics, Montréal, Quebec, Canada
  • Jean-Philippe Sylvestre
    Optina Diagnostics, Montréal, Quebec, Canada
  • Footnotes
    Commercial Relationships   Khaled Nassar Boehringer Ingelheim Pharma GmbH & Co. KG , Code E (Employment); Heiko Niessen Boehringer Ingelheim Pharma GmbH & Co. KG, Code E (Employment); Jean Daniel Arbour Optina Diagnostics, Code C (Consultant/Contractor), Optina Diagnostics, Code I (Personal Financial Interest); Marc-André Rhéaume None; Ramina Nissan Optina Diagnostics, Code C (Consultant/Contractor); Anthéa Rojewski Optina Diagnostics, Code C (Consultant/Contractor); Patricia Sorya Optina Diagnostics, Code C (Consultant/Contractor); Lara Santucci Optina Diagnostics, Code E (Employment); Shannon Campbell Optina Diagnostics, Code E (Employment); Samin Sabokrohiyeh Optina Diagnostics, Code E (Employment); Anudeep Konda Optina Diagnostics, Code E (Employment); Claudia Chevrefils Optina Diagnostics, Code E (Employment), Optina Diagnostics, Code I (Personal Financial Interest); Jean-Philippe Sylvestre Optina Diagnostics, Code E (Employment), Optina Diagnostics, Code I (Personal Financial Interest)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 447. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Khaled Nassar, Heiko Niessen, Jean Daniel Arbour, Marc-André Rhéaume, Ramina Nissan, Anthéa Rojewski, Patricia Sorya, Lara Santucci, Shannon Campbell, Samin Sabokrohiyeh, Anudeep Konda, Claudia Chevrefils, Jean-Philippe Sylvestre; Spatial-spectral characterization and mapping of labeled drusenoid deposits in non-neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2024;65(7):447.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Although the biogenesis of drusenoid deposits is not yet fully understood, it is accepted that they contribute to the functional loss associated with Age-related Macular Degeneration (AMD). This exploratory study is aimed at identifying spatial-spectral features characteristic of soft drusen, hard drusen and reticular pseudodrusen in non-neovascular AMD. We hypothesize that spatial-spectral features extracted from hyperspectral retinal images should permit discrimination between the different types of drusenoid deposits.

Methods : Hyperspectral retinal images captured between 450-905nm in steps of 5 nm, as well as corresponding Optical Coherence Tomography (OCT) scans, were collected for 152 eyes from 100 participants aged 50 and above, with non-neovascular AMD. Using the OCT scans as ground truth, 148 eyes from 97 participants were annotated by eye specialists for their drusenoid deposits. Images were then evaluated using local spectral normalization to identify characteristic spatial-spectral signatures, followed by the exploration of two classification approaches based on these signatures.

Results : Extraction of the mean spectrum of annotated drusenoid deposits after relative background normalization yielded a specific spatial-spectral signature for each drusenoid deposit type (Fig 1A). The annotated drusenoid deposits (Fig 1B) were classified based on their spatial-spectral signature using the Spectral Angle Mapping (SAM) method (Fig 1C). Classification of the annotated regions as drusenoid deposits or healthy retina based on this SAM method resulted in a sensitivity and specificity of 97% and 70%, respectively. Use of a Random Forest classifier provided even better classification, with sensitivity and specificity of 88% and 99%, respectively. Pixel per pixel classification using the SAM method further provided plausible maps of the drusenoid deposits and healthy retina even outside annotated areas (Fig 2B) when compared to the annotated image (Fig 2A).

Conclusions : A spatial-spectral signature was identified for each drusenoid deposit type which enabled promising classification performances. These data suggest that automatic identification of drusenoid deposits based on phenotypic features, rather than anatomical information, could become a reality, and improve patient risk stratification with further research.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×